FAIRFIELD, Conn.--(BUSINESS WIRE)--July 20, 2005--IMS Health (NYSE: RX) today announced second-quarter 2005 revenues of $433.3 million, up 14 percent (12 percent constant dollar), compared with revenues of $379.6 million for the second quarter of 2004. Second-quarter diluted earnings per share on an SEC-reported basis was $0.41, up 52 percent, compared with $0.27 in the 2004 second quarter. Second-quarter adjusted diluted earnings per share was $0.34, compared with $0.29 per share in the same period of 2004, an increase of 17 percent. Net income on an SEC-reported basis was $93.2 million, up 43 percent compared with net income of $65.1 million in the year-earlier quarter. On an adjusted basis, net income for the second quarter of 2005 was $77.8 million, up 12 percent, compared with net income of $69.5 million in the prior year. “Our second-quarter results were strong around the world, led by the U.S. and Europe. In fact, our teams delivered double-digit reported revenue gains in all regions-the Americas, Europe and Asia Pacific,” said David R. Carlucci, IMS chief executive officer and president. “IMS’s outstanding performance demonstrates our continued success in delivering essential market intelligence to help clients with their most critical business decisions. Our momentum is strong, and we remain confident that we will achieve our financial objectives for the year.”
